Autolus Therapeutics plc ADR (AUTL)

Autolus Therapeutics plc ADR Borsa (AUTL) Ultime notizie

Autolus Therapeutics plc (NASDAQ:AUTL) Short Interest Down 7.7% in May - MarketBeat

MarketBeat

Autolus reports promising results for obe-cel in leukemia study - Investing.com India

Investing.com India

Autolus reports promising results for obe-cel in leukemia study By Investing.com - Investing.com

Investing.com

Autolus reports promising results for obe-cel in leukemia study By Investing.com - Investing.com

Investing.com

Autolus Therapeutics plc ADR (AUTL) deserves deeper analysis – US Post News - US Post News

US Post News

Autolus shares hold steady with Buy rating on Obe-cel market penetration By Investing.com - Investing.com

Investing.com

Analyzing Ratios: Autolus Therapeutics plc ADR (AUTL)'s Financial Story Unveiled – DWinneX - The Dwinnex

The Dwinnex

How does Autolus Therapeutics plc ADR (AUTL) change from a tortoise to a hare? – Sete News - SETE News

SETE News

Moving Average Crossover Alert: Autolus Therapeutics - Yahoo News Australia

Yahoo News Australia

Moving Average Crossover Alert: Autolus Therapeutics - Yahoo News Australia

Yahoo News Australia

Victory Capital Management Inc. Makes New Investment in Autolus Therapeutics plc (NASDAQ:AUTL) - Defense World

Defense World

Autolus Therapeutics plc ADR (AUTL) is looking forward to a strong quarter – Sete News - SETE News

SETE News

Is Autolus Therapeutics plc ADR (AUTL) a good investment opportunity? – US Post News - US Post News

US Post News

Daily Market Movement: Autolus Therapeutics plc ADR (AUTL) Sees a -8.43 Decrease, Closing at 4.02 – DWinneX - The Dwinnex

The Dwinnex

Autolus Therapeutics plc ADR (AUTL) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

The InvestChronicle

Investors Take Advantage Of -8.43% Loss In Autolus Therapeutics plc ADR (NASDAQ: AUTL) – Stocks Register - Stocks Register

Stocks Register

Earnings call: Autolus Therapeutics Reports Progress and Financials for Q1 2024 By Investing.com - Investing.com UK

Investing.com UK

Autolus Therapeutics plc ADR (AUTL) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

The InvestChronicle

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates - Investing.com India

Investing.com India

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

GlobeNewswire Inc.

Trading Day Review: Autolus Therapeutics plc ADR (AUTL) Loses Momentum, Closing at 3.93 – DWinneX - The Dwinnex

The Dwinnex

Holdings of Autolus Therapeutics plc ADR (AUTL) are aligned with the stars – Sete News - SETE News

SETE News

Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year? - Yahoo Movies UK

Yahoo Movies UK

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed ... - Investing.com South Africa

Investing.com South Africa

Will Autolus Continue to Surge Higher? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress

GlobeNewswire Inc.

Did Autolus Therapeutics plc ADR (AUTL) perform well in the last session? – US Post News - US Post News

US Post News

How does Autolus Therapeutics plc ADR (AUTL) change from a tortoise to a hare? – Sete News - SETE News

SETE News

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

GlobeNewswire Inc.

Autolus Therapeutics Announces Changes to its Board of Directors

GlobeNewswire Inc.

Autolus Therapeutics appoints new Chairman and Director By Investing.com - Investing.com

Investing.com

Breaking Down Autolus Therapeutics: 4 Analysts Share Their Views

Benzinga

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site

GlobeNewswire Inc.

Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024

GlobeNewswire Inc.

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year?

Zacks Investment Research

Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? - Yahoo Finance

Yahoo Finance

Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength? - Yahoo Finance

Yahoo Finance

Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?

Zacks Investment Research

Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength? - Yahoo Finance

Yahoo Finance

AUTL Stock Quote Price and Forecast - CNN

CNN

Autolus Announces Pricing of Underwritten Offering

GlobeNewswire Inc.

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs  

GlobeNewswire Inc.

2seventy bio, Inc. (TSVT) Surges 28.2%: Is This an Indication of Further Gains?

Zacks Investment Research

2seventy bio, Inc. (TSVT) Surges 28.2%: Is This an Indication of Further Gains? - Yahoo Finance

Yahoo Finance

Autolus Therapeutics Announces Changes to its Board of Directors

GlobeNewswire Inc.

Analyst Expectations for Autolus Therapeutics's Future

Benzinga

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023

GlobeNewswire Inc.

Autolus (AUTL) Selects Cardinal Health for Cell Therapy Supply - Yahoo News UK

Yahoo News UK

Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year? - Yahoo Movies UK

Yahoo Movies UK

The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga

Benzinga